Am J Transplant, Volume 16, Suppl 3 Archives - Page 141 of 180 - ATC Abstracts

2016 American Transplant Congress
Hydrogen Sulfide Treatment Mitigates Donor Tissue Necrosis During Prolonged Cold Storage and Improves Survival Following Allogeneic Renal Transplantation.
I. Lobb,^1,3 W. Liu,² J. Jiang,³ D. Lian,³ A. Sener.^1,3,4
¹Microbiology and Immunology, Western University Canada, London, ON, Canada; ²Pathology, Western University Canada, London, ON, Canada; ³Matthew Mailing Centre for Translational Transplant Studies, London Health Sciences Centre, London, ON, Canada; ⁴Surgery, Western University Canada, London, ON, Canada.
Organ procurement is inherently associated with ischemia-reperfusion injury (IRI), resulting from loss and subsequent restoration of blood flow, which is detrimental to short- and long-term…
2016 American Transplant Congress
Health Insurance Trends in United States Living Kidney Donors.
J. Rodrigue,^1,2 A. Fleishman.¹
¹Surgery, Beth Israel Deaconess Medical Center, Boston, MA; ²Surgery, Harvard Medical School, Boston, MA.
The aim of this study was to examine health insurance trends in living kidney donors (LKDs) in the United States and their association with donor…
2016 American Transplant Congress
A Pilot Study of Donor: A Smart Phone Application for Identifying Live Kidney and Liver Donors.
K. Kumar,¹ E. King,¹ A. Muzaale,¹ J. Konel,¹ G. Segal,³ J. Arnold,³ K. Bramstedt,⁴ D. Segev,^1,2 A. Cameron.¹
¹Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; ²Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD; ³ORGANIZE, New York, NY; ⁴Bond University School of Medicine, Gold Coast, QLD, Australia.
Background: With over 100,000 candidates waiting, rates of deceased donation stagnant, and only 17,000 Kidney and liver transplants a year, live donor transplantation may represent…
2016 American Transplant Congress
An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?
J. Siegel,¹ A. Humar,² P. Gianaros,¹ J. Steel.²
¹Department of Psychology, University of Pittsburgh, Pittsburgh, PA; ²Department of Surgery, Division of Transplantation, University of Pittsburgh, Pittsburgh, PA.
Lack of health insurance has been related lack of access to health care, poorer health, and increased mortality. In this study, we investigate sociodemographic predictors…
2016 American Transplant Congress
Associations of Perfusate Biomarkers and Pump Parameters with Delayed Graft Function and Deceased-Donor Kidney Allograft Function.
C. Parikh,¹ I. Hall,¹ R. Bhangoo,² J. Ficek,¹ P. Abt,³ H. Thiessen-Philbrook,¹ H. Lin,¹ M. Bimali,¹ P. Murray,⁴ V. Rao,¹ B. Schröppel,⁵ M. Doshi,⁶ F. Weng,⁷ P. Reese.³
¹Yale University School of Medicine, New Haven, CT; ²University of Arizona College of Medicine, Phoenix, AZ; ³University of Pennsylvania, Philadelphia, PA; ⁴University College Dublin, Dublin, Ireland; ⁵Mount Sinai School of Medicine, New York, NY; ⁶Wayne State University, Detroit, MI; ⁷Barnabas Health, Livingston, NJ.
Hypothermic machine perfusion (HMP) is increasingly used in deceased-donor kidney transplantation, but controversy exists regarding the value of perfusion biomarkers and pump parameters for assessing…
2016 American Transplant Congress
Don't Judge a Book by Its Cover: Normal Liver Enzymes After Transplantation Can Be Associated with Pathologies Requiring Intervention.
C. Sanchez,¹ S. Kumer,² S. Olson,¹ R. Gilroy,¹ T. Schmitt,² B. Kane,² R. Taylor.¹
¹Hepatology/Transplant, University of Kansas, Kansas City, KS; ²Surgery, University of Kansas, Kansas City, KS.
Background:Liver biopsies are employed post-transplant generally to evaluate abnormal liver enzymes (LE); however they are not without risk. Whether post-transplant protocol biopsies (PB) serve any…
2016 American Transplant Congress
Cardiovascular Prognosis and Adverse Cardiac Events After Orthotopic Liver Transplantation.
L. Potena, V. Manfredini, P. Prestinenzi, R. Alabrese, V. Bertuzzo, L. Borgese, M. Masetti, C. Morelli, F. Grigioni, A. Pinna.
University of Bologna, Bologna, Italy.
Cardiovascular (CV) disease is a major cause of morbidity and mortality among transplant candidate and recipients of noncardiac organs. Aiming to analyze the impact of…
2016 American Transplant Congress
Combined Liver-Kidney Transplantation for Polycystic Liver and Kidney Disease: Analysis from the UNOS Dataset.
C. Coquillard, J. Berger, M. Daily, X. Mei, F. Marti, M. Shah, R. Gedaly.
Surgery, University of Kentucky, Lexington.
Background: The purpose of this study was to evaluate predictors of outcomes in combined liver-kidney (L/K) transplants for PLD/PKD.Methods: We queried the UNOS dataset for…
2016 American Transplant Congress
Differences in Tacrolimus Troughs and Doses Between Caucasians and African Americans with Two CYP3A5 Loss-of-Function Alleles: Looking Beyond CYP3A5 Expression.
W. Oetting,¹ D. Schladt,² W. Guan,¹ R. Remmel,¹ C. Dorr,² K. Sanghavi,¹ A. Matas,¹ R. Mannon,³ A. Israni,² P. Jacobson,¹ For DeKAF Genomics,¹ GEN-03 Investigators.¹
¹University of Minnesota, Minneapolis, MN; ²Hennepin County Medical Center and Minneapolis Medical Research Foundation, Minneapolis, MN; ³University of Alabama, Birmingham, AL.
Higher tacrolimus (TAC) dose requirements and lower TAC troughs (TT) in African Americans (AA) relative to Caucasians (CA) have been presumed to be due to…
2016 American Transplant Congress
Changes in Fatigue After Kidney Transplantation.
H. Ying, I. Olorundare, N. Dagher, B. Lonze, R. Montgomery, M. McAdams-Demarco, D. Segev.
Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
Previous research suggests that 60 to 97% of patients on dialysis experience fatigue, or a feeling of persistent tiredness or exhaustion. ESRD patients with fatigue…